Company Profile - Sesen Bio Inc

Introduction

Carisma Therapeutics Inc (Carisma Therapeutics), formerly Sesen Bio Inc, is a late-stage clinical company that develops targeted fusion protein therapeutics (TFPTs) for the treatment of patients with cancer. The company’s TFPTs genetically combines targeting antibody fragments with cytotoxic protein payloads. Carisma Therapeutics' product pipeline includes Vicinium (VB4-845) also known as oportuzumab monatox, which is used for the treatment of high-grade non-muscle invasive bladder cancer(NMIBC). The company operates in the US, the UK, and Canada. Carisma Therapeutics is headquartered in Cambridge, Massachusetts, the US.